Uber drivers in Victoria have something now that no other gig workers in North America do: an honest-to-goodness collective ...

Dr Reddy’s generic semaglutide launch in Canada signals cheaper obesity treatment and intensifying global competition against ...

I think the main concern with compounded GLP-1s, is that they are not actually assessed or tested by the applicable ...

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, ...

Apotex Inc. ("Apotex" or the "Company"), the largest Canadian‑based global health company, today announced the commercial launch of Apo‑Semaglutide Injection™ – a generic equivalent ...

Plasma donation is done through a process called plasmapheresis. It’s different from whole blood donation, where fluid moves ...

Indian drugmaker Dr Reddy's ​reported an 86% ‌slump in quarterly profit on Tuesday, ​hurt by pricing ​pressure and increasing competition ⁠in its ​key U.S. market.

TheFly reported on April 23 that Goldman Sachs lowered its rating on RDY from Neutral to Sell and reduced the price target ...

India is the first market where Novo Nordisk faces generic competition for semaglutide — the active ingredient in Ozempic and ...

This modern urban area in China features a decorative sailboat installation placed beside a landscaped pedestrian walkway ...

The world has burned through oil inventories at a record speed as the Iran war throttles flows from the Persian Gulf, eating ...

Novo's price cuts lifted Wegovy and Ozempic demand while cheaper GLP-1 therapies expanded India's obesity-drug market.